Adenovirus (ADV) Infection In Pediatric Allogeneic Stem Cell Transplantation (AlloSCT) Recipients Is A Major Independent Factor For Significantly Increasing The Risk Of Treatment Related Mortality

Abstract

Summary Adenovirus infection is a significant complication in paediatric AlloSCT recipients with a mortality rate for disseminated adenovirus that may exceed 80%. We sought to determine the incidence, risk factors, and associated outcomes of adenovirus infection in 123 consecutive paediatric AlloSCT recipients. Adenovirus was diagnosed by antigen detection or viral culture, and was defined by isolation of virus with presence of correlating clinical symptoms. The probability of developing adenovirus infection was 12AE3% (CI95 6AE0‐18AE6). There were no statistically significant differences in probability of adenovirus infection in univariate analysis of risk factors including donor source, use of ATG/Alemtuzumab, ‡Grade II GVHD, among others (age, diagnosis, conditioning regimen). Probability of overall survival for patients that experienced adenovirus infection was 15AE4% vs. 50% for those without adenovirus (P =0 AE0286). In multivariate analysis, the most important risk factor for an increased risk of death was adenovirus infection [HR 3AE15 (CI95 1AE6‐6AE18) P =0 AE0009]. In this series of paediatric AlloSCT recipients, the development of adenovirus infection was the leading multivariate predictor of treatment-related mortality. Enhanced surveillance with adenovirus PCR and identification of the risk factors associated with poor outcomes from adenovirus infection may identify patients that may benefit from pre-emptive therapeutic interventions including adenovirusspecific cellular immunotherapies.